[1]
“Immune Checkpoint Inhibitors and CAR-T Cell Therapy: Thrombotic and Vascular Complications”, acbr, vol. 9, no. 5, pp. 359–364, Sep. 2025, Accessed: Nov. 22, 2026. Available: https://www.fortunejournals.org/ojs/index.php/acbr/article/view/15130